96346-61-1Relevant academic research and scientific papers
Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
-
, (2008/06/13)
This invention describes the use of at least one compound with a progesterone-antagonistic (PA) action and at least one compound with an antiestrogenic (AE) action, each in a non-ovulation-inhibiting dosage in a single dosage unit, for the production of pharmaceutical agents for female contraception.
Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
-
, (2008/06/13)
Competitive progesterone antagonists (antigestagens) are suitable for the production of pharmaceutical agents for the treatment of forms of dysfunctional uterine bleeding (metrorrhagias, menorrhagias, hypermenorrhea).
Use of antigestagens for softening the nonpregnant cervix
-
, (2008/06/13)
Antigestagens are useful for softening the nonpregnant cervix.
